Peter H. Wiernik
Mount Sinai Hospital(US)Lung Cancer Research Foundation(US)The Mark Foundation for Cancer Research(US)Cancer Research Foundation(US)
Publications by Year
Research Areas
Acute Myeloid Leukemia Research, Lymphoma Diagnosis and Treatment, Chronic Lymphocytic Leukemia Research, Acute Lymphoblastic Leukemia research, Chronic Myeloid Leukemia Treatments
Most-Cited Works
- → Hypersensitivity reactions from taxol.(1990)1,172 cited
- → All-trans-Retinoic Acid in Acute Promyelocytic Leukemia(1997)1,092 cited
- → In adults with standard-risk acute lymphoblastic leukemia, the greatest benefit is achieved from a matched sibling allogeneic transplantation in first complete remission, and an autologous transplantation is less effective than conventional consolidation/maintenance chemotherapy in all patients: final results of the International ALL Trial (MRC UKALL XII/ECOG E2993)(2007)780 cited
- → Karyotype is an independent prognostic factor in adult acute lymphoblastic leukemia (ALL): analysis of cytogenetic data from patients treated on the Medical Research Council (MRC) UKALLXII/Eastern Cooperative Oncology Group (ECOG) 2993 trial(2006)746 cited
- → Chemotherapy Compared with Autologous or Allogeneic Bone Marrow Transplantation in the Management of Acute Myeloid Leukemia in First Remission(1998)609 cited